期刊文献+

养胃舒治疗功能性消化不良的临床疗效观察 被引量:1

clinical therapeutic effect of Yangweishu in treating functional dyspepsia(PDS)
下载PDF
导出
摘要 目的:观察养胃舒胶囊联合多潘立酮治疗功能性消化不良(FD)餐后不适综合征患者的临床疗效。方法:将120例功能性消化不良餐后不适综合征的患者随机分为治疗组(60例,加用养胃舒胶囊)和对照组(60例),各组连续服药2周。观察治疗后临床症状的改善情况。结果:治疗2周后两组患者的临床症状均得到显著改善。治疗组总有效率为93.4%,对照组总有效率为83.3%,两组间差异有统计学意义(P<0.05),两组患者均未发生严重不良反应事件。结论:养胃舒胶囊联合多潘立酮治疗功能性消化不良餐后不适综合征较单用多潘立酮疗效显著。 Objective:To observe the clinical therapeutic effect of Yangweishu capsule plus domperidone in treat-ing tunctional dyspepsia(FDS). Methods: 120 patients with functional dyspepsia(PDS) were rwere randomly divided into the treatment group (n=60,plus Yangweishu capsule), thecontrol guoup (n=OO). The treatment ot chmcal symptoms im- proved for 2 weeks.Results:The two groups of patients with clinical symptoms were all improved dramatically, the total effective rate was 93.4% in treatment group and control group was 83.3% after treatment for two weeks respectively, the difference between the two groups had significant statistically signicant (P〈0.05), and two groups were not serious adverse events. Conclusion:The clinical therapeutic effect of Yangweishu capsule plus domperidone in treating func-tional dyspepsia(PDS) was more predominant than single domperidone.
作者 查德义
出处 《安徽卫生职业技术学院学报》 2012年第6期56-57,共2页 Journal of Anhui Health Vocational & Technical College
关键词 功能性消化不良餐后不适综合征 养胃舒胶囊 临床疗效 functional dyspepsia(PDS) Yangweishu capsule clinical efficacy
  • 相关文献

参考文献7

二级参考文献25

  • 1胡伏莲,贾博琦,陈寿坡,林三仁,董秀芸,戴希真,张希全.替普瑞酮对胃溃疡愈合及其愈合质量的影响[J].中华内科杂志,1996,35(12):807-809. 被引量:26
  • 2宋志强,柯美云,王智凤,刘晓红,方秀才.有和无重叠症状的功能性消化不良患者中消化不良症状学和发病机制的比较研究[J].胃肠病学,2006,11(8):458-461. 被引量:27
  • 3Frauke Musial,Sibylle Klosterhalfen,Paul Enck.Placebo responses in patients with gastrointestinal disorders[J].World Journal of Gastroenterology,2007,13(25):3425-3429. 被引量:7
  • 4Tosetti C, Stanghellini V, Tucci A, et al. Gastric emptying and dyspeptic symptoms in patients with nonautoimmune fundic atrophic gastric [J]. Dig Dis Sci,2000,d5:252.
  • 5Jonsson B H,Hellstr6m P M. Motilin and neuropeptide Y like immunoreactivity in a psychophysiological stress experiment on patients with functional dyspepsia [ J ]. Integr Physiol Behav Sci ,2000,35:256.
  • 6Naslund E, Backman L, Theodorsson E, et al. lntraduodenal neuropeptide levels, but not plasma levels, vary in a cyclic fashion with the migrating motor complex [J]. Acta Physiol Scand, 1998,164:317.
  • 7Wang LH,Fang XC,Pan GZ.Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis.Gut,2004,53:1096~1101.
  • 8Fang XC,Ke MY,Pan GZ,Han SM,Qian JM,Ding ZL,Lu SC.Functional gastrointestinal disorders:overlapping symptom or a single complex syndrome? A stratified randomized epidemiologic study by cluster sampling in north China.Gastroenterol,2006,130 (4 supple):A513~A154.
  • 9Drossman DA.The functional gastrointestinal disorders and the Rome Ⅲ process.Gastroenterology,2006,130:1377~1390.
  • 10Tack J,Talley NJ,Camilleri M,Holtmann G,Hu PJ,Malagelada JR,Stanghellini V.Functional gastroduodenal disorders.Gastroenterology,2006,130:1466~1479.

共引文献54

同被引文献19

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部